✦ LIBER ✦

Dose-escalation study of rivaroxaban (BAY 59-7939) – an oral, direct Factor Xa inhibitor – for the prevention of venous thromboembolism in patients undergoing total hip replacement

✍ Scribed by Bengt I. Eriksson; Lars C. Borris; Ola E. Dahl; Sylvia Haas; Menno V. Huisman; Ajay K. Kakkar; Frank Misselwitz; Eva Muehlhofer; Peter Kälebo

Book ID: 116913598
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 302 KB
Volume: 120
Category: Article
ISSN: 0049-3848
DOI: 10.1016/j.thromres.2006.12.025

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Oral, direct Factor Xa inhibition with B

Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement

✍ B. I. ERIKSSON; L. BORRIS; O. E. DAHL; S. HAAS; M. V. HUISMAN; A. K. KAKKAR; F. 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 182 KB

BAY 59-7939: an oral, direct Factor Xa i

BAY 59-7939: an oral, direct Factor Xa inhibitor for the prevention of venous thromboembolism in patients after total knee replacement. A phase II dose-ranging study

✍ A. G. G. TURPIE; W. D. FISHER; K. A. BAUER; L. M. KWONG; M. W. IRWIN; P. KÄLEBO; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 233 KB

A dose escalation study of YM150, an ora

A dose escalation study of YM150, an oral direct factor Xa inhibitor, in the prevention of venous thromboembolism in elective primary hip replacement surgery

✍ B. I. ERIKSSON; A. G. G. TURPIE; M. R. LASSEN; M. H. PRINS; G. AGNELLI; P. KÄLEB 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 569 KB

Treatment of Proximal Deep-Vein Thrombos

Treatment of Proximal Deep-Vein Thrombosis with the Oral Direct Factor Xa Inhibitor Rivaroxaban (BAY 59-7939): The ODIXa-DVT (Oral Direct Factor Xa Inhibitor BAY 59-7939 in Patients with Acute Symptomatic Deep-Vein Thrombosis) Study

✍ G. Agnelli; A. Gallus; S.Z. Goldhaber 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 34 KB

Rivaroxaban-an oral, direct Factor Xa in

Rivaroxaban-an oral, direct Factor Xa inhibitor-for the prevention of venous thromboembolism after total knee replacement: Results of a randomized multi-center trial

✍ Jay R. Lieberman; Nadia Rosencher; Frank Misselwitz 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 20 KB

A dose-ranging study evaluating the oral

A dose-ranging study evaluating the oral factor Xa inhibitor edoxaban for the prevention of venous thromboembolism in patients undergoing total knee arthroplasty

✍ T. FUJI; S. FUJITA; S. TACHIBANA; Y. KAWAI 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 362 KB